The President & CEO of Bellerophon (NASDAQ: BLPH) is Buying Shares

By George MacDonald

Today, the President & CEO of Bellerophon (NASDAQ: BLPH), Jonathan Peacock, bought shares of BLPH for $55.73k.

Jonathan Peacock increased his holding by 64.59% to a total of $1.90. In addition to Jonathan Peacock, one other BLPH executive reported Buy trades in the last month.

The company has a one year high of $12.92 and a one year low of $2.47. BLPH’s market cap is $33.4M and the company has a P/E ratio of 4.6%. Currently, Bellerophon has an average volume of 40.01k.

Three different firms, including Cowen & Co. and FBR Capital, currently also have a Buy rating on the stock.

Looking at blogger coverage of BLPH, there is a 100% Bullish tendency on the stock, in relation to an 80% average bullish tendency within the Healthcare sector.

Over the last 3 months, the insider sentiment on Bellerophon has been neutral based on 36 corporate insider transactions. This sentiment is higher than the average sector sentiment of insiders.

Bellerophon Therapeutics LLC is a clinical-stage therapeutics company developing products at the intersection of drugs and devices that address unmet medical needs in the treatment of cardiopulmonary and cardiac diseases.